Ginkgo Bioworks (DNA) Q1 Revenues Beat; Guides Higher

Ginkgo Bioworks (NYSE: DNA) reported Q1 revenue $168 million versus the consensus estimate of $105.68 million.

GUIDANCE:

Ginkgo Bioworks sees FY2022 revenue of $375-390 million, versus the consensus of $333 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c